HENGRUI PHARMA 01276Hong Kong Stock Exchange

48.0000.91%( -0.440 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
HENGRUI PHARMA (01276) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2025-05-23
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100006XS6
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)37.09B5/112
Net Profit (Last FY)9.04B4/125
ROE (Last FY)12.58%20/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
孙飘扬 Executive Director
戴洪斌 Executive Director
冯佶 Executive Director
张连山 Executive Director
江宁军 Executive Director
孙杰平 Executive Director
郭丛照 Non-Executive Director
楼丽广 Independent Non-Executive Director
曾庆生 Independent Non-Executive Director
孙金云 Independent Non-Executive Director
周纪恩 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-04-16.

About this page

This page shows HENGRUI PHARMA (01276) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.